Europe Newborn Screening Market Forecast to 2030

According to The Research Team’ research, the Europe newborn screening market was valued at US$ 328.04 in 2022 and is expected to reach US$ 653.83 million by 2030, registering a CAGR of 9.0% from 2022 to 2030. Genetic screening of newborns and surging government funding for newborn screening are among the critical factors attributed to the Europe newborn screening market expansion.

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two more examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

On the contrary, lack of uniformity in newborn screening policies and practices hampers the growth Europe newborn screening market.

Based on product type, the Europe newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held 74.2% share of the Europe newborn screening market in 2022, amassing US$ 243.45 million. It is projected to garner US$ 519.58 million by 2030 to expand at 9.9% CAGR during 2022-2030. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Europe newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held 32.7% share of the Europe newborn screening market in 2022, amassing US$ 107.37 million. It is projected to garner US$ 217.89 million by 2030 to expand at 9.2% CAGR during 2022-2030.

Based on test type, the Europe newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held 51.5% share of Europe newborn screening market in 2022, amassing US$ 168.95 million. It is projected to garner US$ 355.19 million by 2030 to expand at 9.7% CAGR during 2022-2030.

By end user, the Europe newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held 65.4% share of Europe newborn screening market in 2022, amassing US$ 214.47 million. It is projected to garner US$ 447.76 million by 2030 to expand at 9.6% CAGR during 2022-2030.

Based on country, the Europe newborn screening market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France held 23.2% share of Europe newborn screening market in 2022, amassing US$ 76.17 million. It is projected to garner US$ 154.60 million by 2030 to expand at 9.3% CAGR during 2022-2030.

Key players operating in the Europe newborn screening market are Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, MRC Holland BV, Natus Medical Inc, PerkinElmer Inc, Waters Corp, and Zentech SA, among others.

– In May 2023, Masimo launched Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data, helping them learn more about and connect better with their baby. The Masimo Stork baby monitor system comprises several components and is available in multiple configurations. Masimo Stork Vitals+, the flagship solution, consists of a boot with a sensor, video camera, and mobile app.

Table 1. Europe Newborn Screening Market Segmentation
Table 2. Europe Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. UK Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. UK Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. Germany Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Germany Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. France Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. France Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. France Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. France Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. France Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. France Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. Italy Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Italy Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. Spain Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Spain Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Europe Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Europe Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 38. Rest of Europe Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Recent Organic Growth Strategies in Newborn Screening Market
Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 42. Glossary of Terms, Newborn Screening Market

Figure 1. Europe Newborn Screening Market Segmentation, By Country
Figure 2. Europe Newborn Screening Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 6. Reagents and Assay Kits: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 9. Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Molecular Assays: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunoassays and Enzymatic Assays: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Pulse Oximetry Screening Technology: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Other Technologies: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 15. Dry Blood Spot Test: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hearing Screen Test: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Other Test Types: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 20. Hospitals and Clinics: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diagnostic Laboratories: Europe Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 23. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 24. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in Newborn Screening Market